Price T Rowe Associates Inc Biote Corp. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Biote Corp. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,709 shares of BTMD stock, worth $52,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,709Holding current value
$52,688% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
90Shares Held
18.5MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$22.4 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$12 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$7.04 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$6.65 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $37.3M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...